CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
2 hedge funds and large institutions have $820K invested in Global X China Biotech Innovation ETF in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$557K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$840K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$20K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $557K | +$557K | +34,297 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $263K | -$840K | -51,675 | -76% |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$20K | -1,205 | Closed |
|